CARE™ mène des évaluations des besoins dans le but de recueillir des commentaires sur les connaissances et la prise en charge actuelles de diverses maladies au Canada. Les résultats sont communiqués avec des commentaires de CARE™ dans les publications de suivi. Nos évaluations des besoins en cours sont accessibles ci-dessous.
Évaluations des besoins
Ouvrir les évaluations des besoins
Résultats des évaluations des besoins
In Q1 of 2019 CARE™ conducted a Needs Assessment on Mantle Cell Lymphoma (MCL) that was directed at hematologists/oncologists across Canada. The aim of this CARE™ program was to gather...
In an effort to promote a shared understanding of the range of issues, perspectives related to the use of asparaginase for adult Acute Lymphocytic Leukemia (ALL) patients in Canada, the...
This needs assessment was distributed by mail and electronically to upwards of 400 Canadian hematologists working in academic teaching centres and/or community practices. The response rate to this needs assessment...
Research led by Dr. Christopher Patriquin and Dr. Loree Larratt Paroxysmal nocturnal hemoglobinuria (PNH) is an ultra-rare, and under-recognized complement-mediated disease. Because of its rarity, it is not well understood....
Biologics have revolutionized the treatment of chronic inflammatory conditions, with significant improvements in efficacy and a manageable safety profile. In the last few years, subsequent entry biologics (SEBs) have been...
